These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 11093654)

  • 1. Quantitative analysis of N-acetylcysteine and its pharmacopeial impurities in a pharmaceutical formulation by liquid chromatography-UV detection-mass spectrometry.
    Toussaint B; Pitti C; Streel B; Ceccato A; Hubert P; Crommen J
    J Chromatogr A; 2000 Oct; 896(1-2):191-9. PubMed ID: 11093654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Capillary electrophoretic separation of N-acetylcysteine and its impurities as a method for quality control of pharmaceuticals.
    Jaworska M; Szulińska G; Wilk M; Tautt J
    J Chromatogr A; 1999 Aug; 853(1-2):479-85. PubMed ID: 10486756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highly efficient, selective, sensitive and stability indicating RP-HPLC-UV method for the quantitative determination of potential impurities and characterization of four novel impurities in eslicarbazepine acetate active pharmaceutical ingredient by LC/ESI-IT/MS/MS.
    Thomas S; Bharti A; Maddhesia PK; Shandilya S; Agarwal A; Dharamvir ; Biswas S; Bhansal V; Gupta AK; Tewari PK; Mathela CS
    J Pharm Biomed Anal; 2012 Mar; 61():165-75. PubMed ID: 22178334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LC determination of rosiglitazone in bulk and pharmaceutical formulation.
    Radhakrishna T; Satyanarayana J; Satyanarayana A
    J Pharm Biomed Anal; 2002 Jul; 29(5):873-80. PubMed ID: 12093521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical practical aspects in the application of liquid chromatography-mass spectrometric studies for the characterization of impurities and degradation products.
    Narayanam M; Handa T; Sharma P; Jhajra S; Muthe PK; Dappili PK; Shah RP; Singh S
    J Pharm Biomed Anal; 2014 Jan; 87():191-217. PubMed ID: 23706957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of impurities in polymyxin B and colistin bulk sample using liquid chromatography coupled to mass spectrometry.
    Van den Bossche L; Van Schepdael A; Chopra S; Hoogmartens J; Adams E
    Talanta; 2011 Feb; 83(5):1521-9. PubMed ID: 21238747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel validated LC method for quantitation of lopinavir in bulk drug and pharmaceutical formulation in the presence of its potential impurities and degradation products.
    Seshachalam U; Haribabu B; Chandrasekhar K
    Biomed Chromatogr; 2007 Jul; 21(7):716-23. PubMed ID: 17370253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemometrically assisted development and validation of LC-UV and LC-MS methods for simultaneous determination of torasemide and its impurities.
    Jovic Z; Zivanovic L; Radisic M; Protic A; Malesevic M
    J Chromatogr Sci; 2012 Apr; 50(4):324-34. PubMed ID: 22407343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification of 3-MCPD and its mercapturic metabolite in human urine: validation of an LC-MS-MS method and its application in the general population.
    Andreoli R; Cirlini M; Mutti A
    Anal Bioanal Chem; 2015 Jun; 407(16):4823-7. PubMed ID: 25862474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of Validated and Stability-Indicating LC-DAD and LC-MS/MS Methods for Determination of Avanafil in Pharmaceutical Preparations and Identification of a Novel Degradation Product by LCMS-IT-TOF.
    Can NÖ
    Molecules; 2018 Jul; 23(7):. PubMed ID: 30029473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of retinoids in galenicals by column liquid chromatography with fluorescence and diode-array detection.
    Gatti R; Gioia MG; Di Pietra AM; Cini M
    J Chromatogr A; 2001 Jan; 905(1-2):345-50. PubMed ID: 11206803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and validation of a gradient HPLC method for the determination of clindamycin and related compounds in a novel tablet formulation.
    Platzer DJ; White BA
    J Pharm Biomed Anal; 2006 Apr; 41(1):84-8. PubMed ID: 16298506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of a liquid chromatographic method for the simultaneous determination of aniracetam and its related substances in the bulk drug and a tablet formulation.
    Papandreou G; Zorpas K; Archontaki H
    J Pharm Biomed Anal; 2011 Nov; 56(3):615-22. PubMed ID: 21742456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New gradient high-performance liquid chromatography method for determination of donepezil hydrochloride assay and impurities content in oral pharmaceutical formulation.
    Kafkala S; Matthaiou S; Alexaki P; Abatzis M; Bartzeliotis A; Katsiabani M
    J Chromatogr A; 2008 May; 1189(1-2):392-7. PubMed ID: 18206895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of N-acetylcysteine in human plasma by liquid chromatography coupled to tandem mass spectrometry.
    Celma C; Allué JA; Pruñonosa J; Peraire C; Obach R
    J Chromatogr A; 2000 Feb; 870(1-2):13-22. PubMed ID: 10722057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous Screening and Quantification of Basic, Neutral and Acidic Drugs in Blood Using UPLC-QTOF-MS.
    Bidny S; Gago K; Chung P; Albertyn D; Pasin D
    J Anal Toxicol; 2017 Apr; 41(3):181-195. PubMed ID: 27881618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of desloratadine in drug substance and pharmaceutical preparations by liquid chromatography.
    Qi M; Wang P; Geng Y
    J Pharm Biomed Anal; 2005 Jun; 38(2):355-9. PubMed ID: 15925231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of unknown compounds in azithromycin bulk samples with liquid chromatography coupled to ion trap mass spectrometry.
    Debremaeker D; Visky D; Chepkwony HK; Van Schepdael A; Roets E; Hoogmartens J
    Rapid Commun Mass Spectrom; 2003; 17(4):342-50. PubMed ID: 12569445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification, characterization and quantification of new impurities by LC-ESI/MS/MS and LC-UV methods in rivastigmine tartrate active pharmaceutical ingredient.
    Thomas S; Shandilya S; Bharati A; Paul SK; Agarwal A; Mathela CS
    J Pharm Biomed Anal; 2012 Jan; 57():39-51. PubMed ID: 21880452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Separation of basic compounds of pharmaceutical interest by using nano-liquid chromatography coupled with mass spectrometry.
    Fanali S; Aturki Z; D'Orazio G; Rocco A
    J Chromatogr A; 2007 May; 1150(1-2):252-8. PubMed ID: 17069825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.